Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background and Aims</h3><p>Accumulating studies identified that BUB1 mitotic checkpoint serine/threonine kinase B (BUB1B) is integrally involved in the initiation and development of tumors. Nevertheless, the precise biological role and underlying mechanisms of BUB1B in hepatocellular carcinoma (HCC) remain indistinct.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Method</h3><p>To figure out the role of BUB1B in HCC, we first assessed its expression using The Cancer Genome Atlas (TCGA) and Gene Expression Profiling Interactive Analysis (GEPIA) databases. We then verified BUB1B expression in HCC tissues, nontumor tissues, and HCC cell lines through western blotting, quantitative reverse transcription‐polymerase chain reaction, and immunohistochemistry. To explore the specific function of BUB1B in HCC in vivo and in vitro, we performed the flow cytometry, Cell Counting Kit‐8, 5‐ethynyl‐2′‐deoxyuridine incorporation, colony formation, Transwell, wound‐healing, subcutaneous tumor growth, and metastasis assays. Additionally, we identified the BUB1B‐regulated pathways involved in HCC by using gene set enrichment analysis.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>Our data displayed that higher BUB1B expression was detected in HCC tissues and HCC cell lines. The overexpression of BUB1B was positively correlated with adverse clinicopathological characteristics. Survival analyses showed that lower recurrence‐free and overall survival rates were correlated with the overexpression of BUB1B in patients with HCC. Moreover, the malignancy of HCC was facilitated by BUB1B both in vivo and in vitro. Lastly, the results were confirmed by western blots, which showed that BUB1B upregulated mTORC1 signaling pathway in HCC. Meanwhile, the oncogenic effect of BUB1B will be impaired when the mTORC1 signaling pathway was inhibited by rapamycin.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusion</h3><p>We highlighted that BUB1B played an oncogenic role in HCC and was identified as a possible clinical prognostic factor and a potential novel therapeutic target for HCC.</p></section>

Research progress of Bub1 in cancers

Research progress on spindle assembly checkpoint gene BubR1]

Bub1 kinase in the regulation of mitosis

Research Progress in the Mechanism of Molecular Targeted Anti-tumor Drugs

Comprehensive analysis of BUBs gene family in lung adenocarcinoma with immunological analysis

Overexpression of BubR1 Mitotic Checkpoint Protein Predicts Short Survival and Influences the Progression of Cholangiocarcinoma

Molecular mechanism underlying the non-essentiality of Bub1 for the fidelity of chromosome segregation in human cells

Impaired Bub1 function in vivo compromises tension-dependent checkpoint function leading to aneuploidy and tumorigenesis

BUB1 induces AKT/mTOR pathway activity to promote EMT induction in human small cell lung cancer

BUB1 as a novel marker for predicting the immunotherapy efficacy and prognosis of breast cancer

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

Zombies Never Die: The Double Life Bub1 Lives in Mitosis

The Predictive Value of BUB1 in the Prognosis of Oral Squamous Cell Carcinoma

bub1 as a potential oncogene and a prognostic biomarker for neuroblastoma

Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin

Expression and prognosis analyses of BUB1, BUB1B and BUB3 in human sarcoma

Expression of the checkpoint kinase BUB1 is a predictor of response to cancer therapies

Budding uninhibited by benzimidazoles 1 might be a poor prognosis biomarker promoting the progression of papillary thyroid cancer

Correlation of BUB1 and BUB1B with the development and prognosis of endometrial cancer

Histone Monoubiquitination in Chromatin Remodelling: Focus on the Histone H2B Interactome and Cancer

BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway